IndieBio

IndieBio is an accelerator firm specializing in Synthetic Biology. The firm runs four month accelerator programs for both companies as well as teams with an idea. It prefers to invest in startups that are using biology as the basis of their technology and invests in seed, early stages too. The firm seeks to make investments in life science, biotechnology, and synthetic biology or around the field of Biotech and businesses that use biology to solve a problem and as the basis of their technology, spanning across processes, products, and software. It seeks to invest in ideas and startups based in any geography. The firm prefers to invest $250k through equity investment. It typically makes cash investment of $50k for exchange of eight percent equity in biotech startups and may receive more $25k as Convertible Loan Note if eligible. The firm prefers to invest in teams with two co-founders minimum rather than a single founder. IndieBio was founded in 2014 and is based in San Francisco, California with an additional office in New York, New York.